Long-axial field-of-view PET/CT for the assessment of inflammation in calcified coronary artery plaques with [<sup>68</sup> Ga]Ga-DOTA-TOC.

Journal Information

Full Title: Eur J Nucl Med Mol Imaging

Abbreviation: Eur J Nucl Med Mol Imaging

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Nuclear Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethical approvalThe cantonal ethics committee approved this patient acquisition (KEK-Nr. 2022–00486). All patients provided written informed consent for inclusion. The study was performed in accordance with the Declaration of Helsinki. Conflict of interestAR has received research support and speaker honoraria from Siemens. All other authors have no conflicts of interest to report. CG received funding from the Swiss National Science Foundation, InnoSuisse, CAIM foundation and GAMBIT foundation, outside of the submitted work. LN is principal investigator of a service agreement with United Imaging Healthcare. UC Davis has a revenue-aharing agreement with United Imaging Healthcare that is based on uEXPLORER sales. LN is site PI of clinical trials supported by Novartis Pharmaceuticals Corporation. LN is PI of clinical trials supported by Telix PHarmaceuticals, Lantheus Medical Imaging and GE Healthcare. LN is Co-I of a clinical trial supported by Lilly.  Conflict of interest AR has received research support and speaker honoraria from Siemens. All other authors have no conflicts of interest to report. CG received funding from the Swiss National Science Foundation, InnoSuisse, CAIM foundation and GAMBIT foundation, outside of the submitted work. LN is principal investigator of a service agreement with United Imaging Healthcare. UC Davis has a revenue-aharing agreement with United Imaging Healthcare that is based on uEXPLORER sales. LN is site PI of clinical trials supported by Novartis Pharmaceuticals Corporation. LN is PI of clinical trials supported by Telix PHarmaceuticals, Lantheus Medical Imaging and GE Healthcare. LN is Co-I of a clinical trial supported by Lilly. "

Evidence found in paper:

"Funding Open access funding provided by University of Bern"

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025